WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): December 31, 2012

                                 BIOCUREX, INC.
                 (Name of Small Business Issuer in its charter)

      Texas                          0-26947                  75-2742601
---------------------           ------------------        ------------------
(State or other jurisdiction   (Commission File No.)      (IRS Employer
of incorporation)                                         Identification No.)

                           7080 River Road, Suite 215
                   Richmond, British Columbia , Canada V6X 1X5
          (Address of Principal Executive Offices, including Zip Code)

       Registrant's telephone number, including area code: (866) 884-8669

          (Former name or former address if changed since last report)


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer; Compensatory Arrangements of Certain Officers. On December 31, 2012 Gladys Chan resigned as the Company's Principal Financial and Accounting Officer. Ms. Chan's resignation was not due to any disagreement with the Company on any matter relating to the Company's operations, policies or practice. 2
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 7, 2012 BIOCUREX, INC. By:/s/ Ricardo Moro ------------------------------------- Dr. Ricardo Moro, President